An interventional study of Posterior lumbar interbody fusion and Inter transverse bone grafting in Lumbar Spondylolisthesis, sponsored by Assiut University. Status unknown. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2017-09-01.
Sponsored by Assiut University · Not applicable, Interventional, and Treatment
The first technique described for interbody fusion was the anterior lumbar interbody fusion (ALIF).(20) For this technique, the intervertebral disc is accessed through a retroperitoneal or transperitoneal approach.
While the posterior approach was first described by Russell Hibbs in 1911, in the 1950's, Cloward (7)popularized the posterior approach for a posterior lumbar interbody fusion (PLIF).
In this study we will try to identify the benefits and outcome of posterior lumbar interbody fusion and inter transverse process bone graft fusion.
227 studies on the registry are indexed under Spondylolisthesis; 43 are open to participants now.
This study's planned enrollment of 30 is below the median of 60 across 143 interventional studies indexed under Spondylolisthesis.
Browse Spondylolisthesis studies →Assiut University is the lead sponsor of 5,078 studies on the registry; 2,178 are open to participants now.
Of its 14 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Procedure: Inter transverse bone grafting
Procedure: Posterior lumbar interbody fusion
Lumbar fusion by screws and inter vertebral cage
Inter transverse process bone grafting by bone graft from illiac crest or other sites
Back pain
Back pain severity grading mild, moderate, severe
Time frame: 1year postoperative
No study locations are listed for this record.
Start is estimated for Sep 2017; primary completion for Aug 2018, 11 months later.
Of 42 non-industry interventional studies with no phase under Spondylolisthesis, half reached primary completion within 38 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 63. This study's planned 11 months is below that.
Counting every sponsor, half of 61 studies reached it within 46 months; a quarter within 16 and three quarters within 65.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Aug 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.